Heramed Ltd · ASX:HMD
Heramed — Investor Presentation (April 2020)
34 slides from Heramed's investor presentation, Apr 7, 2020
Slide 1: Digital Transformation of Maternity Care: US Market Strategy
US Market Presentation | April 2020 For personal use only Digital Transformation of Maternity Care US Market Strategy Presented by Alex Radke US General Manager All Rights Reserved Proprietary and Confidential © 2020 HeraMED Ltd.
Slide 2: Disclaimer
Disclaimer Important notice regarding forward looking statements For personal use only This document contains a general summary of the company and is provided for information purposes only. For full details please review HeraMED Limited ACN 626 295 314 (HeraMED) ASX page - https://www.asx.com.au/asx
Slide 3: Covid-19: Global health challenges present opportunities
Covid-19: Global health challenges present opportunities The outbreak of COVID-19 globally has proven to be one of the most challenging health, social and financial crises in generations and has caused For personal use only fundamental changes in global healthcare system infrastructure. High level o
Slide 4: US Maternity Care is Expensive & Deficient
US Maternity Care is Expensive & Deficient Maternal Mortality Is Rising in the U.S. as 3,791,712 For personal use only It Declines Elsewhere3 2018 Number of Births1 Deaths per 100,000 live births $111 Billion Total Cost of All Payers2 Maternity care represents the second-highest healthcare expenditu
Slide 5: Maternity Care Desert
Maternity Care Desert19 “ For personal use only More than 5 million women live in maternal deserts that have no OB providers “ An additional 10 million women live in countries with limited access to maternity care 5 All Rights Reserved Proprietary and Confidential © 2020 HeraMED Ltd.
Slide 6: HeraCARE Solution
HeraCARE Solution delivers value across insurers, healthcare providers For personal use only and employers in three key categories Cost Reduction Increased Satisfaction Better Outcomes • Reduction of both scheduled and • 24/7 access to midwife consultants • Early detection of potential unscheduled c
Slide 7: The HeraCARE Hybrid Maternity Care Platform
The HeraCARE Hybrid Maternity Care Platform combining high tech with high touch HeraBEAT For personal use only Care Managers HERA Dashboard Maternity Companion Social Network Fetal HR Monitor Powered by Activity Tracker Communication Urine Weight Educational 7 Materials Blood Pressure All Rights Res
Slide 8: HeraCARE – A New Hybrid Maternity Care Paradigm
HeraCARE – A New Hybrid Maternity Care Paradigm digital | connected | home based For personal use only Based on empowerment, education & self-measurement Fully customizable to local prenatal care standards Seamlessly integrated into IT infrastructure of healthcare organizations Optimized adherence t
Slide 9: The Influence of Women in Healthcare
For personal use only The Influence of Women in Healthcare 90% are primary healthcare decision makers for their family & key influencers for friends8 80% of the household healthcare spending is done by women8 Women are 75% more likely to use digital tools for healthcare than men8 87% of women said t
Slide 10: The Challenges Of Maternity Care
The Challenges Of Maternity Care The pregnancy experience hasn’t changed since the 50’s For personal use only DOCTORS/ PROVIDERS EXPECTING MOTHERS Shortage of fundamental services 14+ clinical sessions per pregnancy Lack of time and attention Loss of time away from work / family Low reliability of a
Slide 11: The HeraMED Flywheel
The HeraMED Flywheel HeraMED’s platform enhances supply-side effectiveness, generating increased demand engagement, which drives a self-reinforcing cycle of care for pregnant women For personal use only Market Healthier Patient Access Mothers & Engagement Babies Service Provider Supply Demand Suppor
Slide 12: The Basics of Healthcare as a Business
The Basics of Healthcare as a Business Payment For personal use only Revenue/Benefit: Revenue/Benefit: Insurance premium from patient Payment from insurer (majority) + Cost: patient (minority) Payment to provider Cost: Delivery of care to patient Payer Provider Enrollment Treatment Patient Revenue/B
Slide 13: US Market Development Strategy
US Market Development Strategy Providers Payers For personal use only + Telehealth Midwives Opportunities Opportunities Employers Insurance Hospitals Doctors Companies 13 All Rights Reserved Proprietary and Confidential © 2020 HeraMED Ltd.
Slide 14: Maternity Care Cost Savings
For personal use only Maternity Care Cost Savings Self-insured employers Hospitals For every dollar spent in prenatal • Complications add, on average, 20% to the cost of care – a vaginal delivery and 25% to the cost of a c-section employers are saving • Severe maternal morbidity (SMM) escalates the
Slide 15: Maternity Care Cost Savings Opportunities
Maternity Care Cost Savings Opportunities Example Cost Complications cost (Per case): Annual Cost: For personal use only $32K Postpartum depression10 ~$14B $18K c-section vs $10K Vaginal11 ~$9B $14K Preeclampsia per delivery12 ~$2.18B $ 32K Preterm birth first year vs $3K13 ~$26B $12,800 from payer
Slide 16: Healthcare Providers - Leading Opportunity
Healthcare Providers - Leading Opportunity Healthcare Large healthcare providers tend to be self insured For personal use only creating a unique alignment between employer, provider and payer – all in one. Their interest is to keep employees healthy while providing Employer Provider Payer them with
Slide 17: Strategy for Targeting Providers
Strategy for Targeting Providers • Leverage demonstrated success of pregnancy homecare programs (OB Nest) For personal use only • Gain additional clinical buy-in and validation of outcome measures • Position HeraMED as a leader through clinical support Health System Doctor’s Clinics • Pilot & produc
Slide 18: Strategy for Targeting Payers
Strategy for Targeting Payers • Present clinical validation from providers For personal use only • Offer reduced cost of care model Employers • Emphasize better patient satisfaction • Large employers (>1,000 employees) • Self-insured Women’s Health Insurance Coverage 2018 • Self-insured orgs are ful
Slide 19: Insurance Companies are Taking Notice
Insurance Companies are Taking Notice The US’s largest health insurers all have a focus on maternal care payment reform For personal use only U.S. Women's Health Alliance Launches First-Ever, National Maternity Episode of Care November 13, 2017 The U.S. Women's Health Alliance, in collaboration with
Slide 20: Employers are Taking Notice
For personal use only Employers are Taking Notice Average Cost of Employee Health Care Makes Up 7.6 Percent of a Company’s Annual Operating Budget16 • Pregnancy and childbirth account for 25 percent of all hospitalizations in the United States17 • The US is the only developed country in the world wi
Slide 21: US Market Tailwinds Favorable to HeraMED
US Market Tailwinds Favorable to HeraMED Market adjacent companies have demonstrated viable pathways to market success For personal use only 1 Digital Health Adoption Digital chronic disease management platform • IPO: July 2019 • Market Cap: $2.5 Bn 2 Fertility Coverage Expansion Fertility benefits
Slide 22: US Market Pathway to Success
For personal use only US Market Pathway to Success Deepen & Align ourselves Grow market Continuously expand health with the share through deliver clinical system leading voices channel outcomes & relationships expansion financial savings 22 All Rights Reserved Proprietary and Confidential © 2020 Her
Slide 23: 2020 Work Plan
2020 Work Plan* The company anticipates some milestones to be accelerated while others might be delayed due to the Covid19 operational and financial challenges • Mayo Clinic Collaboration For personal use only • Commercial HeraCARE release • Initiate Orion AI • Orion release V1.0 and clinical trial
Slide 24: HeraMED's Path to Commercialisation
HeraMED’s Path to Commercialisation Growth For personal use only Current stage: stage Extended FDA US Market analysis identifying clearance for home use $$ trends and opportunities and Growing International defining strategy FDA partnerships and Design and development of the network $$$ Clinical Her
Slide 25: End-to-End Solution Drives Multi-Stakeholder Value
End-to-End Solution Drives Multi-Stakeholder Value For personal use only Patients Clinical Staff Hospitals Empowerment Improved outcomes Operational Efficiency Convenience Patient satisfaction Customer Loyalty Peace of Mind Reduced burden Innovation Identity Employers Insurance Companies Researchers
Slide 26: Appendix
For personal use only Appendix All Rights Reserved Proprietary and Confidential © 2020 HeraMED Ltd.
Slide 27: Footnotes
Footnotes 1. https://www.cdc.gov/nchs/data/nvsr/nvsr68/nvsr68_13-508.pdf 2. http://www.pbgh.org/maternity For personal use only 3. https://www.npr.org/2017/05/12/528098789/u-s-has-the-worst-rate-of-maternal-deaths-in-the-developed-world 4. https://www.cdc.gov/nchs/data/nvsr/nvsr68/nvsr68_13-508.pdf
Slide 28: Case Study: Livongo
For personal use only Case Study Livongo All Rights Reserved Proprietary and Confidential © 2020 HeraMED Ltd.
Slide 29: Livongo: Business Model
For personal use only Livongo: Business Model Connected Medical Sales & Marketing Self-Insured Employers Note: Actual early adopters Devices $$$ Digital Health Coaches Employees Chronic Care Management Coaching https://ir.livongo.com/static-files/a1340ee4-27a2-4df0-91ff-078f04325134 All Rights Reser
Slide 30: Livongo's Multi-Channel Approach
For personal use only Livongo’s Multi-Channel Approach https://ir.livongo.com/static-files/a1340ee4-27a2-4df0-91ff-078f04325134 All Rights Reserved Proprietary and Confidential © 2020 HeraMED Ltd.
Slide 31: Livongo's Value Creation & Results
For personal use only Livongo’s Value Creation & Results Value Delivery Pathway Customer Value Prop User Engagement Decrease cost of care to employers for employees Clinical Outcomes with chronic conditions Employer Savings https://ir.livongo.com/static-files/a1340ee4-27a2-4df0-91ff-078f04325134 All
Slide 32: Product Features Centered Around End-User
Product Features Centered Around End-User For personal use only https://ir.livongo.com/static-files/a1340ee4-27a2-4df0-91ff-078f04325134 All Rights Reserved Proprietary and Confidential © 2020 HeraMED Ltd.
Slide 33: Key Lessons for HeraMED
Key Lessons for HeraMED KEY TAKEAWAYS For personal use only • Clinically validated care model and clearly defined outcome measures • Developed data-set to unlock additional sales channels • Clear value prop to payment source (i.e. insurers) • Market entry through self-insured employers • Progressive
Slide 34: Alexander Radke – Short Bio
Alexander Radke – Short Bio Mr Radke was previously the Senior Vice President at Signals Analytics, a leading For personal use only business intelligence platform focused on providing market insights to Fortune 500 brands including Proctor & Gamble, Nestle, Johnson & Johnson, Roche, Novartis